Skip to:

NEWS

Jun 16 | iPSC-derived hepatocytes for drug identification and to study cellular pathophysiology


Cayo et al. have made an impressive work using new techniques such as iPSCs and humanized mice, to show that cardiac glycosides reduces hepatocyte production of apoB. They use apoB ELISA from Mabtech to analyze apoB secreted from iPSC-derived hepatocytes, and apoB in serum of avatar mice.

...read more

Jun 15 | Use of R848 and IL-2 to stimulate memory B cells


In 2013, Jahnmatz, M et al published a newly developed protocol for polyclonal activation of human memory B cells. The authors showed the superior functionality of stimulating B cells using the TLR7/8-agonist R848 and IL-2 compared to the other stimulation protocols used at the time.

...read more

"We have been using Mabtech antibodies in our ELISpot assays for several years with satisfaction. Recently we switched to the IFN/gamma/TNF-alpha Fluorospot assay in kit version and found it to consistently produce good quality results while effectively tripling our collection of functional data. The team at Mabtech assisted us during this transition, which resulted in a short optimisation and therefore minimal delay in continuing with our experiments. "
Jade Clarson
GVL and Immunotherapy
Cancer Theme
South Australian Health and Medical Research Institute (SAHMRI)
"Amazing! Your delivery time system is really efficient. We are really impressed about it."
Susana Gargallo
ARACLON BIOTECH, S.L.,
"Our research group uses Mabtech products for a variety of applications, especially investigating immunological responses in wildlife. We have been able to develop new assays for detecting diseases and feel that the quality of the products contributes to our research progress. The support from the Mabtech staff has been especially positive and we look forward to future collaborations."
Michelle Miller
Division of Molecular Biology & Human Genetics
Faculty of Medicine and Health Sciences
Stellenbosch University